Host: |
Rat |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rat monoclonal antibody anti-Atrogin-1 (N-Term) is suitable for use in Western Blot research applications. |
Clonality: |
Monoclonal |
Clone ID: |
M314 |
Conjugation: |
Unconjugated |
Isotype: |
N.T. |
Formulation: |
PBS + 1 mg/ml BSA, 0.05% NaN3 and 50% glycerol |
Purification: |
Antigen Affinity Purified |
Dilution Range: |
WB 1:500IHCICCIP |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
Fbxo32 |
Gene ID: |
67731 |
Uniprot ID: |
FBX32_MOUSE |
Immunogen Region: |
N-Term |
Specificity: |
This antibody detects a full length human recombinant Atrogin 1 on SDS-PAGE immunoblots. |
Immunogen: |
Clone M314 was generated from a synthetic peptide (coupled to carrier protein) corresponding to amino acids from the N-terminal region of mouse Atrogin. This sequence is highly homologous to human and rat Atrogin (F-box only protein 32). |
Tissue Specificity | Specifically expressed in cardiac and skeletal muscle. |
Function | Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Probably recognizes and binds to phosphorylated target proteins during skeletal muscle atrophy. Recognizes TERF1. |
Protein Name | F-Box Only Protein 32Atrogin-1Muscle Atrophy F-Box ProteinMafbx |
Database Links | Reactome: R-MMU-8951664Reactome: -MMU-983168 |
Cellular Localisation | CytoplasmNucleusShuttles Between Cytoplasm And The Nucleus |
Alternative Antibody Names | Anti-F-Box Only Protein 32 antibodyAnti-Atrogin-1 antibodyAnti-Muscle Atrophy F-Box Protein antibodyAnti-Mafbx antibodyAnti-Fbxo32 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance